Utilization of authorization within Vitrolife to repurchase own shares

The Annual General Meeting on April 29, 2008, of Vitrolife AB (publ) approved the proposal to authorize the Board of Directors to acquire the company’s own shares for the purpose of adjusting the company’s capital structure and/or use repurchased shares in connection with the acquisition of a company or business. The company’s Board has now decided to utilize this authorization.

The shares will be purchased over the OMX Nordic Exchange Stockholm at a price within the quoted price range at any given time when the Board finds it favourable for the company’s shareholders.

Purchase can be made as of August 2, 2008, until the next Annual General Meeting in 2009. No acquisitions will be made during a 30-day period prior to the announcement of quarterly results, the day of announcement included.

The total number of outstanding shares in Vitrolife is 19,800,157 and the maximum number of shares which can be repurchased is 1,980,015.



August 1, 2008
Kungsbacka, Sweden

Vitrolife AB (publ)







Queries should be addressed to:
Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61.
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.